Physiological immunohistochemical and molecular aspects of gastric adaptation to stress, aspirin and to H. pylori - Derived gastrotoxins

Journal of Physiology and Pharmacology

Volumn 48, Issue 1, 1997, Pages 3-42

  Konturek, P Ch ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

aspirin; cytoprotection; growth factors; prostaglandins; stress

Indexed keywords

ACETYLSALICYLIC ACID; AMMONIA; ANTIULCER AGENT; BACTERIAL TOXIN; BASIC FIBROBLAST GROWTH FACTOR; CAPSAICIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; IRRITANT AGENT; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PHOSPHOLIPID; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR ALPHA; TREFOIL PEPTIDE; UNINDEXED DRUG;

ADAPTATION; ANIMAL MODEL; CELL PROLIFERATION; CELL PROTECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHYSIOLOGY; REVIEW; SENSORY NERVE; STOMACH MUCOSA LESION; STOMACH MUCUS; STOMACH PROTECTION; STRESS ULCER; ULCER HEALING;

ANALGESICS, NON-NARCOTIC; ANIMALS; ASPIRIN; BACTERIAL TOXINS; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; STRESS, PSYCHOLOGICAL;

EID: 0030986095     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Crawford JM. The Gastrointestinal Tract. In: Pathologic Basis of Disease, AS Cotran, V Kumar and S Robbins (eds), 1994, pp. 755-829.
2. Hollander D, Tarnawski A. Gastric Cytoprotection. A Clinical Guide. New York, Plenum, 1989.
3. Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761-767.
4. Robert A, Nazamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, Hypertonic NaCl and thermal injury. Gastroenterology 1979; 77: 433-443.
5. Konturek S, Radecki T, Brzozowski T, Dembinska-Kiec A, Gryglewski R. Gastric Cytoprotection by epidermal growth factor. Role of endogenous prostaglandins and DNA synthesis. Gut 1981; 81: 438-443.
6. Konturek SJ. Mechanisms of gastroprotection. Scand J Gastroenterol 1990; 25 (Suppl 174): 15-28.
7. Robert A, Nezamis JT, Davies JP, Field SA, Handcar AJ. Mild irritants prevent gastric necrosis through "adaptive" cytoprotection mediated by prostaglandins. Am J Physiol 1983; 245: G113-121.
8. Konturek SJ, Brzozowski T, Piastucki I, Radecki T, Dembinska-Kiec A. Role of locally generated prostaglandins in adaptive gastric cytoprotection. Dig Dis Sci 1982; 27: 967-971.
9. Masferer JL, Isakson PC, Seibert K. Cyclooxygenase-2 inhibitors. Gastroenterol Clin N Am 1996; 25: 363-372.
10. Ito S, Lacy ER, Rutten MJ, Critchlow J, Silen W. Rapid repair of injured gastric mucosa. Scand J Gastroenterol 1984; 19 (Suppl 101): 87-96.
11. Tarnawski A, Hollander D, Stachura J, Krause WJ, Gergely H. Prostaglandins protection of the gastric mucosa against alcohol injury: A dynamic title-related process. Role of muscular proliferative zone. Gastroenterology 1985; 88: 334-354.
12. Paimela H, Goddard PJ, Carter K et al. Restitution of frog gastric mucosa in vitro: Effect of basis fibroblast growth factor. Gastroenterology 1993; 104:1337-1345.
13. Konturek SJ, Brzozowski T, Konturek PC, Majka J, Dembinski A. Role of salivary glands and epidermal growth factor in gastric secretion and mucosal integrity in rats exposed to stress. Regul Pept 1991; 32: 203-215.
14. Tepperman BL, Soper BD, Morris GP. Effect of sialoadenectomy on adaptive cytoprotection in the rat. Gastroenterology 1989; 97: 123-129.
15. Konturek PCh, Konturek SJ, Brzozowski T, Ernst H. Epidermal growth factor and transforming growth factor-alpha: role in protection and healing of gastric mucosal damage. Eur J Gastroenterol Hepatol 1995; 7: 933-338.
16. Endo K, Kao J, Bomek MJ, Leung FW. Mechanism of gastric hyperemia induced by intragastric hypertonic saline in rats. Gastroenterology 1993; 104: 114-121.
17. MacNaughton WK, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective action in the stomach. Life Sci 1989; 45: 1869-1876.
18. Whittle BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99: 607-611.
19. Holzer P, Lippe ITh. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa. Neuroscience 1988; 27: 971-977.
20. Brzozowski T, Drozdowicz D, Majka J, Konturek SJ. Studies on gastroprotection induced by capsaicin and papaverine. J Physiol Pharmacol 1992; 43: 309-322.
21. Konturek SJ, Konturek PC. Role of nitric oxide in digestive system. Digestion 1995; 56: 1-13.
22. Konturek PC, Brzozowski T, Hahn EG. Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide. Eur J Pharmacol 1997 (in press).
23. Konturek SJ, Brzozowski T, Majka J, Czarnobilski K. Role of nitric oxide and prostaglandins in sucralfate-induced gastroprotection. Eur J Pharmacol 1992; 211: 277-279.
24. Konturek SJ, Brzozowski T, Marks NJ et al. Antacids and mucosal protection. Eur J Gastroenterol Hepatol 1992; 4: 954-965.
25. Moody FG, Cheung LY, Simons MA, Salensky C. Stress and the acute gastric mucosal lesions. Dig Dis Sci 1976; 21: 148-154.
26. Ludwig WM, Lipkin M. Biochemical and cytological alterations in gastric mucosal of guinea pigs under restraint stress. Gastroenterology 969; 56: 895-902.
27. Hamajima E, Sugiyama S, Hoshino H, Goto H, Tsukamoto Y, Ozawa T. Effect of FK506 and immunosuppresive agent on genesis of water immersion stress-induced gastric lesions in rats. Dig Dis Sci 1994; 39: 713-720.
28. Brzozowski T, Konturek SJ, Pytko-Polonczyk J, Warzecha Z. Gastric adaptation to stress: Role of sensory nerves, salivary glands and adrenal glands. Scand J Gastroenterol 1995; 30: 6-16.
29. Konturek PC, Brzozowski T, Konturek SJ et al. Activation of genes for growth factors and cyclooxygenases in the rat gastric mucosa during recovery from stress damage. Eur J Pharmacol 1997 (in press).
30. Konturek PC, Brzozowski T, Konturek SJ et al. Role of spasmolytic peptide in healing of stress-induced gastric lesions in rats. Reg Pept 1997 (in press).
31. Konturek PC, Ernst H, Brzozowski T, Ihlm A, Hahn EG, Konturek SJ. Expression of epidermal growth factor and transforming growth factor alpha after exposure of gastric mucosa to stress. Scand J Gastroenterol 1996; 31: 209-216.
32. Brzozowski T, Konturek PCh., Stachura J. Gastric adaptation to aspirin and stress enhances gastric mucosal resistance against the damage by strong irritant Scand J Gastroenterol 1996; 31: 118-125.
33. Konturek PCH, Brzozowski T, Konturek SJ, Dembinski A. Role of epidermal growth factor, prostaglandins and sulfhydryls in stress-induced gastric lesions. Gastroenterology 1990; 99: 1607-1615.
34. Konturek SJ, Piastucki I, Brzozowski T, Dembinska-Kiec A, Gryglewski R. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology 1981:80:4-9.
35. Whittle BJR. Temporal relationship between cyclooxygenase inhibition as measured by prostacyclin biosynthesis and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1991; 80: 94-98.
36. Ivey KJ, Paone DB, Krause WJ. Acute effects of systemic aspirin on gastric mucosa in man. Dig Dis Sci 1980; 25: 97-99.
37. McCarthy MD. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy. J Clin Gastroenterol 1990; 12 (suppl 12): 513-520.
38. Wallace JL, Keenan Ch, Granger DN. Gastric ulceration by non-steroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990; 259: G462-467.
39. Wallace JL. Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: Pathogenesis and mechanisms re-examined. Scand J Gastroenterol 1992; 27 (suppl 192): 3-8.
40. Treventhick MA, Clayton NM, Stong P, Harman IW. Do infiltrating neurophils contribute to the pathogenesis of indomethacin induced ulceration of the rat gastric antrum. Gut 1993; 34: 153-160.
41. Wallace JL, McKnight W, Miyasaka M, Kubes P, Granger DN. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol 1993; 265: G993-998.
42. Andrews EJ, Malcontenti-Wilson C, O'Brien PE. Effect of non-steroidal anti-inflammatory drugs on LFA and ICAM-1 expression in gastric mucosa. Am J Physiol 1994; 266: G657-664.
43. Konturek SJ, Brzozowski T, Stachura J, Majka J. Role of neutrophils and mucosal blood flow in gastric adaptation to aspirin. Eur J Pharmacol 1994; 253: 107-114.
44. Robert A, Lancaster C, Olafsson AS, Gilberston-Beadling S, Zhang W. Gastric adaptation to the ulcerogenic effect of aspirin. Gastroenterology 1991; 1: 73-90.
45. Konturek SJ, Brzozowski T, Stachura J, Dembinski A, Majka J. Role of gastric blood flow and mucosal cell proliferation in gastric adaptation to aspirin in the rat. Gut 1994; 35: 1189-1196.
46. Shorrock CJ, Rees WPW. Mucosal adaptation to indomethacin induced gastric damage in man. Studies on morphology, blood flow and prostaglandin E metabolism. Gut 1992; 33: 164-169.
47. Konturek JW, Dembinski A, Stoll R, Domschke W, Konturek SJ. Mucosal adaptation to aspirin induced gastric damage in humans. Studies on blood flow, gastric mucosal growth and neutrophil activation. Gut 1994; 35: 1197-1204.
48. Stachura J, Konturek SJ, Brzozowski T, Konturek JW, Domschke W. Pathologic basis of mucosal adaptation to topical injury. J Gastroenterol 1995; 30: 416-427.
49. Brzozowski T, Konturek PC, Konturek SJ, Ernst H, Stachura J, Hahn EG. Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defense against subsequent exposure to various strong irritants in rats. Gut 1995; 37: 749-757.
50. Romano M, Lesch C, Meise KS et al. Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats. Gastroenterology 1996; 110: 1446-1455.
51. Wright NA, Pike C, Elia G. Induction of an epithelial growth factor-secreting lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990; 343: 82-85.
52. Thim L. Trefoil peptides: a new family of gastrointestinal molecules. Digestion 1994; 55: 553-560.
53. Cover TL, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med 1996; 41: 81-117.
54. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 1996; 110: 926-938.
55. Konturek PCH, Konturek SJ, Konturek JW. Gastric secretion and the pathogenesis of peptic ulcer in the Helicobacter pylori infection. J Physiol Pharmacol 1996; 47: 5-20.
56. Marshall BJ, Barrett LJ, Parakash C, McCallum RW, Guerrant RL. Urea protects Helicobacter (Campylobacter pylori) from the bactericidal effect of acid. Gastroenterology 1990; 99: 697-702.
57. McGowan CC, Cover TL, Blaser MJ. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 1994; 107: 1523-1578.
58. Ferrero RL, Lee A. The importance of urease in acid protection for the gastric colonizing bacteria Helicobacter pylori and Helicobacter felis. Microb Ecol Health Dis 1991; 4: 121-134.
59. Eaton K-A, Krakowka S. Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect Immun 1994; 62: 3604-3607.
60. Chen XG, Correa D, Offerhaus J et al. Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol 1986; 86: 575-582.
61. Quigley EMM, Turnberg LA. PH of the microclimate lining human gastric and duodenal mucosa in vitro. Gastroenterology 1987; 92: 1876-1883.
62. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfill Kochs postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436-439.
63. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192-199.
64. Graham DY, Alpert LC, Smith Jl, Yoshimura HH. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988; 83: 974-980.
65. Hoffman JS, King WW, Fix JG, Jank D, Cave DR. Rabbit and ferret parietal cell inhibition by Helicobacter species. Dig Dis Sci 1995; 40: 147-152.
66. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJH, Tytgat GNJ. Mucosal tumor necrosis factor-, interleukin-1 and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-429.
67. Tarnasky PR, Kovacs YTO, Sytnik B, Walsh JH. Asymptomatic H pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Dig Dis Sci 1993; 38: 1681-1687.
68. Konturek JW, Konturek SJ, Domschke W. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. Scand J Gastroenterol 1995; 30: 738-744.
69. Olbe L, Hamlet A, Dalenback J, Fandriks L. A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 1996; 110: 1386-1394.
70. El-Omar EM, Penman ID, Ardill JES, Chittajalln RS, Howie C, McColl KEL. Helicobacter infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-691.
71. Graham DY, Opekun A, Lew GM, Evans DJ, Klein PD, Evans DG. Ablation exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990; 85: 394-398.
72. Konturek JW, Bielanski W, Konturek SJ, Domschke W. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. J Physiol Pharmacol 1996; 47: 161-175.
73. Mulholland G, Ardill JE, Fillmore D, Chittajallu RS, Fullarton GM, McColl KEL. Helicobacter pylori related hypergastrinemia is the result of a selective increase in gastrin 17. Gut 1993; 34: 737-761.
74. Moss SF, Legon S, Bishop AE, Polak JM, Calan J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-932.
75. Queiroz DM, Mendes EN, Rocha GA et al. Effect of Helicobacter pylori eradication on antral gastrin-and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 1993; 28: 858-864.
76. Kaneko H, Nakoda K, Mitsuma T et al. Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci 1992; 37: 409-416.
77. Nujumi AM, Dorrian CA, Chittajallu RS, Neithercul WD, McColl KEL. Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer patients. Gut 1991; 32: 866-870.
78. Konturek PC, Ernst H, Konturek JW et al. Salivary and luminal release of epidermal growth factor under basal conditions and after pentagastrin-stimulation in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. J Physiol Pharmacol 1996; 47: 187-194.
79. Kim H, Park C, Lee KH et al. The gastric juice area and ammonia levels in patients with Campylobacter pylori. Am J Clin Pathol 1990; 94: 197-191.
80. Xu JK, Goodwin S, Cooper M, Robinson J. Intracellular vacuolation caused by the urease of Helicobacter pylori. J Infect Dis 1990; 161: 1302-1304.
81. Megraud F, Neman SV, Brugmann D. Further evidence of the tonic effect of ammonia produced by Helicobacter pylori in human epithelial cells. Infect Immun 1992; 60: 1860-1863.
82. Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59: 2470-2475.
83. Murakami M, Yoo JK, Inada M, Miyake T. Effect of ammonia on the gastric mucosa in rats: Pathophysiological importance of urease in gastric ulcer disease. Jpn J Pharmacol 1988; 47: 330-332.,
84. Kawano S, Tsujii M, Fusamoto H, Sato N, Kamada T. Chronic effect of intragastric ammonia on gastric mucosa structures in rats. Dis Dis Sci 1991; 36: 33-38.
85. Tsujii M, Kawano S, Tsujii S, Fusamoto H, Sato N. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology 1992; 102: 1881-1888.
86. Murakami M, Saita H, Teramura S et al. Gastric ammonia has a potent ulcerogenic action on the rat stomach. Gastroenterology 1993; 105: 1710-1715.
87. Takeuchi K, Ohuchi T, Hiroyuki H, Okabe S. Irritant and protective action of urea-urease ammonia in rats gastric mucosa. Dig Dis Sci 1995; 40: 274-281.
88. Brzozowski T, Konturek PC, Konturek SJ, Ernst H, Sliwowski K, Hahn EG. Mucosal irritation, adaptive cytoprotection and adaptation to topical ammonia in rats stomach. Scand J Gastroenterol 1996; 31: 837-846.
89. Konturek SJ, Konturek PC, Brzozowski T, Stachura J, Zembala Z. Gastric mucosal damage and adaptive protection by ammonia and ammonium ion in rats. Digestion 1996; 57: 433-435.